Experimental models used in evaluating anti-tuberculosis vaccines: the latest advances in the field
Introduction: Tuberculosis is an infectious disease which is caused by bacilli from the M. tuberculosis complex. The Mycobacterium bovis Bacillus Calmette-Guérin vaccine is currently available as a prophylactic tool for preventing the disease; it has been shown to be efficient in preventing dissemin...
Main Authors: | Alejandra Mantilla Galindo, Marisol Ocampo, Manuel Alfonso Patarroyo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-04-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2019.1583558 |
Similar Items
-
Liposomal delivery system/adjuvant for tuberculosis vaccine
by: Melika Moradi, et al.
Published: (2023-06-01) -
Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches
by: Zafran Khan, et al.
Published: (2022-06-01) -
An Overview of the Development of New Vaccines for Tuberculosis
by: E. Whitlow, et al.
Published: (2020-10-01) -
What's new in tuberculosis vaccines?
by: Ginsberg Ann M.
Published: (2002-01-01) -
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
by: Fangbin Zhou, et al.
Published: (2023-11-01)